Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

St. Jude Diversifies In Intra-Coronary Assessment Market With $90 Mil. Buy

This article was originally published in The Gray Sheet

Executive Summary

St. Jude Medical is upping the ante in the coronary lesion assessment space with the $90 million cash acquisition of LightLab Imaging

You may also be interested in...



Abbott Can Sell St. Jude’s Intravascular Assessment Tools Under Expanded Alliance

Rights for Abbott to promote and distribute intravascular optical coherence tomography imaging and fractional flow reserve products from St. Jude Medical are added to an existing co-promotion pact between the firms.

A Bright Future For Optical Imaging

One bright spot emerging in this otherwise lackluster economy is the market for optical imaging technologies. Optical imaging encompasses a wide array of current and emerging techniques that use light as the primary imaging modality to characterize local anatomy down to cellular and molecular levels.

EuroPCR Highlights: TAVI Set to Continue Rampant Growth

With innovation as the theme of this year's EuroPCR meeting, emerging technology sessions and innovation presentations sparked lively discussions. While drug-eluting stents remained a key interest area, transcatheter aortic heart valve implantation sessions drew the largest crowds.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028925

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel